With the stock's current price at Rs 2819.60, GlaxoSmithKline Pharmaceuticals is navigating through market dynamics, ...

ICICI Securities recommended reduce rating on GlaxoSmithKline Pharmaceuticals with a target price of Rs 2,600 in its research ...

GSK Pharmaceuticals reports a temporary production disruption due to a fire at one of its contract manufacturing facilities; ...

NBCC: The company has successfully sold 446 residential units at Aspire Silicon City in Noida through an e-auction, generating Rs 1,468 crore in sales. Additionally, it will receive a marketing fee of ...

GlaxoSmithKline Pharmaceuticals, operating in the Pharmaceuticals sector and classified as a Midcap on the BSE, currently has its share price at ₹2728.1. The stock has experienced fluctuations ...

The company is working closely with the contract manufacturing facility for resumption of operations. Shares of ...

Amazon and Samara Capital-backed supermarket chain More Retail is planning to raise around Rs 2,000 crore through an initial public offer (IPO), which is expected to hit the market in the calendar ...

GlaxoSmithKline Pharmaceuticals reported a 36% increase in net profit to Rs 263 crore in the March quarter, up from Rs 194 ...

Profit before tax stood at Rs 354.90 crore, up 32.08% from Rs 268.71 crore in the same period last year. Total expenses ...

GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) reported a 9% revenue growth, predominantly led by volume growth. The company achieved a 30% growth in EBITDA, with margins improving from 26% to ...

GlaxoSmithKline Pharmaceuticals Ltd. reported a 36% increase in consolidated net profit to Rs 263 crore for the quarter ended ...

Todays focus will be on GSK Pharma shares in light of the companys announced topline growth and profitability for the full ...